Plant- based Metabolites as Source of Antimicrobial Therapeutics: Prospects and Challenges
- Title
- Plant- based Metabolites as Source of Antimicrobial Therapeutics: Prospects and Challenges
- Creator
- Praveen N.; Preetha R.S.T.; Pagare V.; Devasia J.; Nizam A.; Mukherjee E.; Vasantha V.L.; Al-Khayri J.M.
- Description
- Plants are used as traditional medicines from ancient times to today as they are the largest living storehouses of bio- chemicals and pharmaceuticals known on Earth (Abdallah, 2011). The World Checklist of Vascular Plants (WCVP) database reported in April 2021 that there are 1,383,297 plant names with 996,093 plants identified at species level, constituting 342,953 accepted vascular plant species (Govaerts et al., 2021). Around 10% of the reported vascular plants are used as medicines (Salmer- Manzano et al., 2020). According to the MPNS, 33,443 species are recorded as being used for medicinal purpose (MNPS, 2021). Medicinal plants are those that have therapeutic properties which can pose pharmacological effect on the human or animal body (Namdeo, 2018). About 80% of the world's population depends on plant- based medicine for treatment of diseases (Okoye et al., 2014). The medicinal property of a plant is attributed to rich and diverse secondary metabolites (Allemailem, 2021). Secondary metabolites are intermediates or products of primary metabolism that are not involves directly in the growth and development of the plant (Jain et al., 2019). Plants generate secondary metabolites in response to stresses posed by biotic factors (bacteria, fungi, viruses, parasites, pests, weeds, and herbivore animals) and abiotic environmental factors (temperature, salinity, drought, UV radiation etc.) so as to adapt and survive in response to environmental stimuli during their life time (Yang et al., 2018). 2023 selection and editorial matter, Arti Gupta and Ram Prasad; individual chapters, the contributors.
- Source
- Antimicrobials in Pharmaceutical and Medicinal Research, pp. 165-202.
- Date
- 2023-01-01
- Publisher
- CRC Press
- Coverage
- Praveen N., Department of Life Sciences, CHRIST (Deemed to be University), Hosur Road, Bangalore, India; Preetha R.S.T., Department of Life Sciences, CHRIST (Deemed to be University), Hosur Road, Bangalore, India; Pagare V., Department of Life Sciences, CHRIST (Deemed to be University), Hosur Road, Bangalore, India; Devasia J., Department of Chemistry, CHRIST (Deemed to be University), Hosur Road, Bangalore, India; Nizam A., Department of Chemistry, CHRIST (Deemed to be University), Hosur Road, Bangalore, India; Mukherjee E., Amity Institute of Biotechnology, Amity University, Noida, India; Vasantha V.L., Department of Life Sciences, CHRIST (Deemed to be University), Hosur Road, Bangalore, India; Al-Khayri J.M., Department of Agricultural Biotechnology, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa, Saudi Arabia
- Rights
- Restricted Access
- Relation
- ISBN: 978-100084553-2; 978-100326893-2
- Format
- Online
- Language
- English
- Type
- Book chapter
Collection
Citation
Praveen N.; Preetha R.S.T.; Pagare V.; Devasia J.; Nizam A.; Mukherjee E.; Vasantha V.L.; Al-Khayri J.M., “Plant- based Metabolites as Source of Antimicrobial Therapeutics: Prospects and Challenges,” CHRIST (Deemed To Be University) Institutional Repository, accessed February 23, 2025, https://archives.christuniversity.in/items/show/18474.